Analysts Set Expectations for Aldeyra Therapeutics, Inc's Q1 2023 Earnings (NASDAQ:ALDX)
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) – Oppenheimer issued their Q1 2023 EPS estimates for shares of Aldeyra Therapeutics in a report issued on Thursday, March 9th. Oppenheimer analyst J. Kim expects that the biotechnology company will post earnings of ($0.26) per share for the quarter. The consensus estimate for Aldeyra Therapeutics’ current full-year […]